ELATIVE Safety Data
IQIRVO is a second-line treatment for PBC with a safety profile comparable to UDCA alone5
IQV-UK-000160 | November 2024


This section of the website is for UK Healthcare Professionals only. If you are not a Healthcare Professional, please click here.
IQIRVO is a second-line treatment for PBC with a safety profile comparable to UDCA alone5
IQV-UK-000160 | November 2024